Cargando…

Ultrasonography evaluation on the protective effect of combination therapy of beraprost sodium and aspirin on arteries occlusion and stiffness in patients with type 2 diabetes mellitus - a prospective, randomized study

BACKGROUND: Patients with type 2 diabetes mellitus (T2DM) are susceptible to developing symptomatic peripheral arterial disease (PAD). As a proven vasodilator and antiplatelet agent, the efficiency of Beraprost sodium (BPS) on the prevention of arteries occlusion and stiffness in T2DM patients with...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lin, Xian, Chen, Yuying, Lu, Wan, Li, Jin, Fu, Li, Yin, Jingyu, Ren, Meng, Yan, Li, Yang, Chuan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2022
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8977025/ https://www.ncbi.nlm.nih.gov/pubmed/35366853 http://dx.doi.org/10.1186/s12902-022-01007-5

Ejemplares similares

Effect of beraprost sodium on arterial stiffness in patients with type 2 diabetic nephropathy
por: Na, Ki Young, et al.
Publicado: (2013)

Beneficial Effect of Beraprost Sodium Plus Aspirin in the Treatment of Acute Ischemic Stroke
por: Chen, Siqia, et al.
Publicado: (2017)

Combination therapy with beraprost sodium and aspirin for acute ischemic stroke: a single-center retrospective study
por: Cai, De, et al.
Publicado: (2019)

Beraprost sodium protects against chronic brain injury in aluminum-overload rats
por: Pan, Yongquan, et al.
Publicado: (2015)

Effects of Beraprost Sodium on Subjective Symptoms in Diabetic Patients with Peripheral Arterial Disease
por: Yoon, Hang Seob, et al.
Publicado: (2013)

Ameliorative Effect of Beraprost Sodium on Celecoxib Induced Cardiotoxicity in Rats
por: Ahmad, Shafique, et al.
Publicado: (2018)

Vascular Endothelium as a Target of Beraprost Sodium and Fenofibrate for Antiatherosclerotic Therapy in Type 2 Diabetes Mellitus
por: Otsuki, Michio, et al.
Publicado: (2005)

Beraprost Sodium for Pulmonary Hypertension in Dogs: Effect on Hemodynamics and Cardiac Function
por: Suzuki, Ryohei, et al.
Publicado: (2022)

Beraprost Sodium Delays the Decline of Glomerular Filtration Rate in Patients with Diabetic Nephropathy: A Retrospective Study
por: Zhou, Jingjing, et al.
Publicado: (2023)

Investigation of Beraprost Sodium on Cardiac Function and Hemodynamics in Canine Models of Chronic Pulmonary Hypertension
por: Suzuki, Ryohei, et al.
Publicado: (2022)

Clinical efficacy and safety of beraprost sodium in the treatment of nephrotic syndrome: A meta-analysis
por: Yan, Peng, et al.
Publicado: (2023)

Correction to: Beraprost Sodium Delays the Decline of Glomerular Filtration Rate in Patients with Diabetic Nephropathy: A Retrospective Study
por: Zhou, Jingjing, et al.
Publicado: (2023)

The Protective Effect of Beraprost Sodium on Diabetic Cardiomyopathy through the Inhibition of the p38 MAPK Signaling Pathway in High-Fat-Induced SD Rats
por: Li, Jie, et al.
Publicado: (2014)

Catalytic asymmetric formal synthesis of beraprost
por: Kobayashi, Yusuke, et al.
Publicado: (2015)

Effect of hypoxia and Beraprost sodium on human pulmonary arterial smooth muscle cell proliferation: the role of p27(kip1)
por: Kadowaki, Maiko, et al.
Publicado: (2007)

The Prostacyclin Analog Beraprost Sodium Ameliorates Characteristics of Metabolic Syndrome in Obese Zucker (Fatty) Rats
por: Sato, Nahoko, et al.
Publicado: (2010)

Beraprost sodium attenuates the development of myocardial fibrosis after myocardial infarction by regulating GSK‐3β expression in rats
por: Li, Xing‐Xing, et al.
Publicado: (2023)

Prospective analysis of the efficacy of beraprost sodium combined with alprostadil on diabetic nephropathy and influence on rennin-angiotensin system and TNF-α
por: Xu, Xinwei, et al.
Publicado: (2020)

The Protective Effect of Beraprost Sodium on Diabetic Nephropathy by Inhibiting Inflammation and p38 MAPK Signaling Pathway in High-Fat Diet/Streptozotocin-Induced Diabetic Rats
por: Peng, Li, et al.
Publicado: (2016)

Beraprost and Overall Survival in Cats with Chronic Kidney Disease
por: Ito, Hiroyuki, et al.
Publicado: (2023)

Short-Term Effects of Beraprost Sodium on the Markers for Cardiovascular Risk Prediction in Type 2 Diabetic Patients with Microalbuminuria
por: Choi, Yun Mi, et al.
Publicado: (2019)

Prostacyclin analog beraprost sodium efficacy in primary glomerular disease or nephrosclerosis: Analysis of the Japanese subgroup in CASSIOPEIR study
por: Kurumatani, Hajimu, et al.
Publicado: (2021)

Effect of beraprost on pulmonary hypertension due to left ventricular systolic dysfunction
por: Wang, Li, et al.
Publicado: (2019)

Efficacy of Beraprost Sodium Combined with Sildenafil and Its Effects on Vascular Endothelial Function and Inflammation in Patients Experiencing Left Heart Failure Complicated with Pulmonary Arterial Hypertension
por: Sun, Daoyuan, et al.
Publicado: (2021)

A Double‐blind, Placebo‐controlled, Multicenter, Prospective, Randomized Study of Beraprost Sodium Treatment for Cats with Chronic Kidney Disease
por: Takenaka, M., et al.
Publicado: (2017)

Beraprost sodium versus clopidogrel for preventing vascular thromboembolic events of arteriovenous fistula in uraemic patients: a retrospective study with a mean 3-year follow-up
por: Wan, Ziming, et al.
Publicado: (2018)

Beraprost sodium preconditioning prevents inflammation, apoptosis, and autophagy during hepatic ischemia-reperfusion injury in mice via the P38 and JNK pathways
por: Deng, Jingfan, et al.
Publicado: (2018)

Aspirin Preventing Occlusion after Coil Migration into the Distal Anterior Cerebral Artery
por: Craven, Claudia L, et al.
Publicado: (2020)

Beraprost ameliorates postmenopausal osteoporosis by regulating Nedd4-induced Runx2 ubiquitination
por: Zheng, Huo-Liang, et al.
Publicado: (2021)

Comparing the vascular thromboembolic events following arteriovenous fistula in Chinese population with end-stage renal diseases receiving Clopidogrel versus Beraprost sodium therapy: a retrospective cohort study
por: Zhou, Yu, et al.
Publicado: (2018)

Aspirin use in central retinal arterial occlusion to prevent ischaemic stroke: a retrospective cohort study in Taiwan
por: Kang, Eugene Yu-Chuan, et al.
Publicado: (2019)

De Novo Synthesis of Dihydrobenzofurans and Indolines and Its Application to a Modular, Asymmetric Synthesis of Beraprost
por: Wang, Ze-Shu, et al.
Publicado: (2023)

Aspirin plus clopidogrel versus aspirin alone for the prevention of coronary artery bypass graft occlusion: angiographic and clinical results of a randomized study
por: Dalmau, Maria J, et al.
Publicado: (2015)

Orally active prostacyclin analogue beraprost sodium in patients with chronic kidney disease: a randomized, double-blind, placebo-controlled, phase II dose finding trial
por: Koyama, Akio, et al.
Publicado: (2015)

A multinational phase IIb/III trial of beraprost sodium, an orally active prostacyclin analogue, in patients with primary glomerular disease or nephrosclerosis (CASSIOPEIR trial), rationale and study design
por: Nakamoto, Hidetomo, et al.
Publicado: (2014)

Clinical Significance of Arterial Stiffness and Thickness Biomarkers in Type 2 Diabetes Mellitus: An Up-To-Date Meta-Analysis
por: Yapei, Yang, et al.
Publicado: (2015)

Prevalence of and risk factors for aspirin resistance in elderly patients with coronary artery disease
por: Liu, Xian-Feng, et al.
Publicado: (2013)

Platelet Endothelial Aggregation Receptor 1 Polymorphism Is Associated With Functional Outcome in Small-Artery Occlusion Stroke Patients Treated With Aspirin
por: Li, Zhizhang, et al.
Publicado: (2021)

Systematic review the efficacy and safety of cilostazol, pentoxifylline, beraprost in the treatment of intermittent claudication: A network meta-analysis
por: Liang, Xinyu, et al.
Publicado: (2022)

SAT-LB011 Role of Endothelium Epithelial Sodium Channel in Arterial Stiffness
por: Jia, Guanghong, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_cd8tms9cogo3apoh8g4fu6jgog